Inventiva Pharma

IPO

Public · Daix, France · Founded 2010 · $232.0M raised

Headquarters
Daix
Employees
51–200
Founded
2010
Business Model
B2B
Total Funding
$232.0M
Last Round
$116.0M Growth EquityMay 2025
Rounds
3
Type
Public

About

Inventiva is a clinical-stage biopharmaceutical company focused on developing oral small molecule therapies for patients with significant unmet medical needs in fibrosis, lysosomal storage disorders, and oncology. Its lead candidate, lanifibranor, is a pan-PPAR agonist in Phase 3 trials for NASH/MASH with breakthrough therapy designation from the FDA. The company has built an extensive proprietary molecule library and wholly-owned R&D capabilities inherited from Abbott, Solvay, and Fournier.

Summary

Inventiva Pharma is a Biopharmaceutical company based in Daix, France, founded in 2010. It has raised $232.0M in total across 3 rounds, most recently a $116.0M Growth Equity round in May 2025.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPOPublic OfferingNov 2025
$150.0M

Sign up to see all 4 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Inventiva Pharma on Indexed.vc
<a href="https://indexed.vc/companies/inventiva-pharma"><img src="https://indexed.vc/api/badge/company/inventiva-pharma" alt="Inventiva Pharma on Indexed.vc" width="260" height="76" /></a>